// App-Quantinova.ai

TCT-323 : Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a National Cohort

Researchers

Presenter

  • Warkaa Shamkhani

Principal Investigators

  • Tim Kinnaird

  • Harindra Wijeysundera

  • Peter Ludman

  • Muhammad Rashid

  • Mamas Mamas

Medical Centers

  • Sunnybrook Health Sciences Centre/University of Toronto, Toronto, Ontario, Canada

  • Royal Stoke Hospital, Keele University, Stoke-On-Trent, United Kingdom

  • QUEEN ELIZABETH HOSPITAL, Birmingham, United Kingdom

  • University Hospital of Wales, Cardiff, United Kingdom

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved